133 related articles for article (PubMed ID: 30248161)
1. Non-Invasive Gene Expression Testing to Rule Out Melanoma.
Rivers JK; Copley MR; Svoboda R; Rigel DS
Skin Therapy Lett; 2018 Sep; 23(5):1-4. PubMed ID: 30248161
[TBL] [Abstract][Full Text] [Related]
2. Utility of a Noninvasive 2-Gene Molecular Assay for Cutaneous Melanoma and Effect on the Decision to Biopsy.
Ferris LK; Jansen B; Ho J; Busam KJ; Gross K; Hansen DD; Alsobrook JP; Yao Z; Peck GL; Gerami P
JAMA Dermatol; 2017 Jul; 153(7):675-680. PubMed ID: 28445578
[TBL] [Abstract][Full Text] [Related]
3. Real-world performance and utility of a noninvasive gene expression assay to evaluate melanoma risk in pigmented lesions.
Ferris LK; Gerami P; Skelsey MK; Peck G; Hren C; Gorman C; Frumento T; Siegel DM
Melanoma Res; 2018 Oct; 28(5):478-482. PubMed ID: 30004988
[TBL] [Abstract][Full Text] [Related]
4. Impact on clinical practice of a non-invasive gene expression melanoma rule-out test: 12-month follow-up of negative test results and utility data from a large US registry study.
Ferris LK; Rigel DS; Siegel DM; Skelsey MK; Peck GL; Hren C; Gorman C; Frumento T; Jansen B; Yao Z; Rock J; Knezevich SR; Cockerell CJ
Dermatol Online J; 2019 May; 25(5):. PubMed ID: 31220892
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive Analysis of High-Risk Driver Mutations and Gene Expression Profiles in Primary Cutaneous Melanoma.
Ferris LK; Moy RL; Gerami P; Sligh JE; Jansen B; Yao Z; Cockerell CJ
J Invest Dermatol; 2019 May; 139(5):1127-1134. PubMed ID: 30500343
[TBL] [Abstract][Full Text] [Related]
6. Economic Analysis of a Noninvasive Molecular Pathologic Assay for Pigmented Skin Lesions.
Hornberger J; Siegel DM
JAMA Dermatol; 2018 Sep; 154(9):1025-1031. PubMed ID: 29998292
[TBL] [Abstract][Full Text] [Related]
7. Gene Expression Analysis Differentiates Melanomas from Spitz Nevi.
Jansen B; Hansen D; Moy R; Hanhan M; Yao Z
J Drugs Dermatol; 2018 May; 17(5):574-576. PubMed ID: 29742191
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a noninvasive 2-gene molecular assay for cutaneous melanoma.
Gerami P; Yao Z; Polsky D; Jansen B; Busam K; Ho J; Martini M; Ferris LK
J Am Acad Dermatol; 2017 Jan; 76(1):114-120.e2. PubMed ID: 27707590
[TBL] [Abstract][Full Text] [Related]
9. Dermoscopic features associated with 3-GEP PLA: LINC00518, PRAME, and TERT expression in suspicious pigmented lesions.
Ludzik J; Becker AL; Latour E; Lee C; Witkowski A
Skin Res Technol; 2023 Apr; 29(4):e13323. PubMed ID: 37083005
[TBL] [Abstract][Full Text] [Related]
10. Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.
Serban ED; Farnetani F; Pellacani G; Constantin MM
Acta Dermatovenerol Croat; 2018 Apr; 26(1):64-67. PubMed ID: 29782304
[TBL] [Abstract][Full Text] [Related]
11. Development of a novel noninvasive adhesive patch test for the evaluation of pigmented lesions of the skin.
Gerami P; Alsobrook JP; Palmer TJ; Robin HS
J Am Acad Dermatol; 2014 Aug; 71(2):237-44. PubMed ID: 24906614
[TBL] [Abstract][Full Text] [Related]
12. Analytical Characteristics of a Noninvasive Gene Expression Assay for Pigmented Skin Lesions.
Yao Z; Allen T; Oakley M; Samons C; Garrison D; Jansen B
Assay Drug Dev Technol; 2016 Aug; 14(6):355-63. PubMed ID: 27505074
[TBL] [Abstract][Full Text] [Related]
13. Breslow depth of cutaneous melanoma: impact of factors related to surveillance of the skin, including prior skin biopsies and family history of melanoma.
Fisher NM; Schaffer JV; Berwick M; Bolognia JL
J Am Acad Dermatol; 2005 Sep; 53(3):393-406. PubMed ID: 16112344
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic performance of expert dermoscopists vs a computer-vision system on small-diameter melanomas.
Friedman RJ; Gutkowicz-Krusin D; Farber MJ; Warycha M; Schneider-Kels L; Papastathis N; Mihm MC; Googe P; King R; Prieto VG; Kopf AW; Polsky D; Rabinovitz H; Oliviero M; Cognetta A; Rigel DS; Marghoob A; Rivers J; Johr R; Grant-Kels JM; Tsao H
Arch Dermatol; 2008 Apr; 144(4):476-82. PubMed ID: 18427041
[TBL] [Abstract][Full Text] [Related]
15. Update and clinical use of imaging technologies for pigmented lesions of the skin.
O'Donnell AT; Kim CC
Semin Cutan Med Surg; 2012 Mar; 31(1):38-44. PubMed ID: 22361288
[TBL] [Abstract][Full Text] [Related]
16. Potential Limitations in the Clinical Adoption of 3-GEP Pigmented Lesion Assay for Melanoma Triage by Dermatologists and Advanced Practice Practitioners.
Ludzik J; Lee C; Witkowski A
Cureus; 2022 Nov; 14(11):e31914. PubMed ID: 36579219
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of the diagnosis of pigmented tumors of the skin and factors leading to a decision to excise. Dermatologists of the Postgraduate Association of Haute-Normandie].
Collas H; Delbarre M; De Preville PA; Courville P; Neveu C; Dompmartin A; Balguerie X; Lemaistre B; Rzeznik JC; Thiebot B; Boullie MC; Bravard P; Michel Y; Krug M; Le Corvaisier-Pieto C; Young P; Thomine E; Boivin C; Ziade J; Pellerin A; Hellot MF; Leroy D; Lauret P; Benichou J; Joly P
Ann Dermatol Venereol; 1999; 126(6-7):494-500. PubMed ID: 10495858
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive genomic detection of melanoma.
Wachsman W; Morhenn V; Palmer T; Walls L; Hata T; Zalla J; Scheinberg R; Sofen H; Mraz S; Gross K; Rabinovitz H; Polsky D; Chang S
Br J Dermatol; 2011 Apr; 164(4):797-806. PubMed ID: 21294715
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Raman Spectroscopy for Reducing Unnecessary Biopsies for Melanoma Screening.
Zhang Y; Moy AJ; Feng X; Nguyen HTM; Sebastian KR; Reichenberg JS; Wilke CO; Markey MK; Tunnell JW
Molecules; 2020 Jun; 25(12):. PubMed ID: 32575717
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
